SNWT, AGRT, CGEN, PSDV, TLCV and IFNY are the Dec. 22nd Daily Market Movers Digest Picks from OTCPicks.com

Dallas- OTCPicks.com’s Daily OTC Stocks Newsletter presents a range of the hottest small cap, micro cap and penny stocks trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and micro cap traders to meet up and discuss their top stock picks.

Visit http://www.otcpicks.com/hotpicks.htm today to sign up for our Free Daily Email Newsletter and News Alerts.

SAN WEST INCORPORATED (OTCBB: SNWT)

"Up 9.85% in morning trading"

San West designs, manufacturers, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies; products are sold via three divisions: at retail store locations; via the online store and; through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee California retail location.

AGR TOOLS INCORPORATED (OTCBB: AGRT)

As a global leader in the manufacturing of high quality diamond tools, AGR Tools has been serving the construction and natural stone industries worldwide since 1983. AGR Stone & Tools USA, Inc. is the only manufacturer of a complete line of diamond tools designed for maximum performance for each application. Our products include turbo blades, polishing pads, cup wheels, core bits, tile blades, masonry blades, concrete blades, CNC tooling, engineered stone products and other high-end diamond tools.

COMPUGEN LIMITED (NASDAQ: CGEN)

"Up 72.18% in morning trading"

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based on in silico (by computer) prediction and selection utilizing a growing number of field focused proprietary discovery platforms accurately modeling biological processes at the molecular level. The resulting product candidates are then validated through in vitro and in vivo experimental studies and out-licensed for further development and commercialization under various forms of revenue sharing agreements. Compugen’s collaborations to date include Bayer Schering Pharma, Biosite, Medarex, Inc., Merck & Co., Inc., Merck Serono, Ortho-Clinical Diagnostics (a Johnson & Johnson company), Pfizer, Roche, Siemens Healthcare Diagnostics, Inc., and Teva Pharmaceutical Industries. In 2002, Compugen established an affiliate, Evogene Ltd. (TASE: EVGN), to utilize certain of the Company’s in silico predictive discovery capabilities in agricultural biotechnology.

PSIVIDA CORPORATION (NASDAQ: PSDV)

"Up 54.55% in morning trading"

pSivida is a world leader in the development of tiny, sustained release, drug delivery products that are administered by implantation, injection or insertion. pSivida’s lead development product delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME). This product candidate, formerly known as Medidur™ FA for DME, is licensed to Alimera, which is conducting fully-recruited Phase III clinical trials and intends to commercialize the product under the name Iluvien®. pSivida also has two products approved by the Food and Drug Administration (FDA): Retisert® for the treatment of posterior uveitis and Vitrasert® for the treatment of AIDS-related cytomegalovirus (CMV) retinitis. pSivida has licensed both of these products and the technologies underlying them to Bausch & Lomb Incorporated. pSivida has a worldwide collaborative research and license agreement with Pfizer Inc. under which Pfizer may develop additional ophthalmic products. pSivida owns the rights to develop and commercialize a modified form of silicon known as BioSilicon™, which has potential therapeutic applications. The most advanced BioSilicon product candidate, BrachySil™, delivers a therapeutic P32, a radioactive form of phosphorus used to treat cancer, directly to solid tumors. pSivida conducted an initial safety clinical trial of BrachySil for the treatment of pancreatic cancer and in October 2009 completed a follow-on dose-ranging clinical trial. pSivida’s intellectual property portfolio consists of 62 patent families, over 100 granted patents, including patents accepted for issuance, and over 200 patent applications. pSivida conducts its operations from Boston in the United States and Malvern in the United Kingdom.

TLC VISION CORPORATION (NASDAQ: TLCV)

"Up 18.59% in morning trading"

TLCVision is North America's premier eye care services company, providing eye doctors with the tools and technologies needed to deliver high-quality patient care. Through its centers' management, technology access service models, extensive optometric relationships, direct to consumer advertising and managed care contracting strength, TLCVision maintains leading positions in Refractive, Cataract and Eye Care markets.

INFINITY ENERGY RESOURCES INCORPORATED (OTC: IFNY)

"Up 10.48% in morning trading"

Infinity Energy Resources, Inc. is an independent energy company engaged in the exploration, development and production of natural gas and oil in Texas and the Rocky Mountain region of the United States. The Company also has oil and gas concessions covering 1.4 million acres offshore Nicaragua in the Caribbean Sea.

About OTCPicks.com

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap and penny stocks. The web site features growing micro cap and penny stock companies. We publish a daily Free email newsletter highlighting the most active Pinksheets, OTCBB and penny stocks. To feature a company on our web site please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has been compensated two thousand five hundred dollars by a third party (BlueWave Advisors) for AGRT advertising and promotional services. OTCPicks.com has been previously compensated three thousand five hundred dollars by a third party (Green Horseshoe) for SNWT advertising and promotional services. Currently OTCPicks.com is being compensated two thousand five hundred dollars by a third party (BlueWave Advisors) for SNWT advertising and promotion.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.